MedPath

PIOGLITAZONEHYDROCHLORIDE

These highlights do not include all the information needed to use pioglitazone hydrochloride safely and effectively. See full prescribing information for pioglitazone hydrochloride. Pioglitazone Tablets, USP for oral use Initial U.S. Approval: 1999

Approved
Approval ID

f428d7d7-dbb1-4112-a651-5e0df7227cb8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 1, 2021

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PIOGLITAZONEHYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code63187-746
Application NumberANDA091298
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 1, 2021
Generic NamePIOGLITAZONEHYDROCHLORIDE

INGREDIENTS (5)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CARBOXYMETHYLCELLULOSE CALCIUMInactive
Code: UTY7PDF93L
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
PIOGLITAZONE HYDROCHLORIDEActive
Quantity: 30 mg in 1 1
Code: JQT35NPK6C
Classification: ACTIM
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PIOGLITAZONEHYDROCHLORIDE - FDA Drug Approval Details